Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Standard of Care × Gynecologic × Clear all

Phase

Status

Sponsor Class

OTHER 24 INDUSTRY 4 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 3 Genitourinary 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Peritoneal Neoplasms 1

Interventions

Cisplatin 63 Paclitaxel 56 Carboplatin 38 Taxes 24 Radiotherapy 21 Gemcitabine 16 Brachytherapy 15 Filgrastim 14 Doxorubicin 13 Topotecan 12 Platinum 12 1,2-diaminocyclohexaneplatinum II citrate 12 Docetaxel 11 Radiation 7 Granulocyte Colony-Stimulating Factor 7 Chemotherapy, Adjuvant 7 pegfilgrastim 6 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 6 Polymerase Chain Reaction 6 Ifosfamide 6 Etoposide 6 Watchful Waiting 5 Radiotherapy, Conformal 5 Pemetrexed 5 Gene Expression Profiling 5 Fluorouracil 5 Celecoxib 5 Amifostine 5 Observation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001748 2026-03-23

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡